CI 914

Known as: CI-914 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2010
024619852010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The effects of CI-914, a novel cardiotonic agent, on AA metabolism in rat neutrophils and platelets in vitro were investigated… (More)
Is this relevant?
1990
1990
The impact of changes in the activation state of the low Km cAMP phosphodiesterase (PDE) on cAMP output in adipocyte membranes… (More)
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Ventricular muscle contains a low Km, cyclic AMP-specific form of phosphodiesterase (PDE III), which is believed to represent the… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
1987
1987
A series of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones was synthesized and evaluated for positive inotropic… (More)
Is this relevant?
1986
1986
Hemodynamic response after intravenous and oral administration of a new phosphodiesterase inhibitor, CI-914, was studied in 13… (More)
Is this relevant?
1986
1986
The purpose of this study was to evaluate the effect of the new cardiotonic, imazodan (CI-914), on myocardial hemodynamics and… (More)
Is this relevant?
Highly Cited
1986
Highly Cited
1986
Multiple molecular forms of cyclic nucleotide phosphodiesterase have been identified previously in several tissues and cell types… (More)
Is this relevant?
1986
1986
The hemodynamic effects of CI-914, a phosphodiesterase inhibitor, were studied in 12 patients with left ventricular (LV… (More)
Is this relevant?
1985
1985
CI-914 is a novel positive inotropic agent whose cardiotonic activity is not due to inhibition of Na+, K+-ATPase or to… (More)
Is this relevant?
1985
1985
In the present study, the inhibitory effects of CI-914, a novel cardiotonic agent, as well as other recently identified positive… (More)
Is this relevant?